| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $21.14 ▲ +4.50% | Yesterday | $20.55 ▼ -1.56% | Tomorrow's Syndax Pharmaceuticals Inc. Common Stock (SNDX) setup is anchored to $20.23 and targets $21.14 (+4.50%). The near-term read is upside; watch $20.85 / $19.83 because daily realized volatility is about 3.20%. |
Tomorrow's Syndax Pharmaceuticals Inc. Common Stock (SNDX) setup is anchored to $20.23 and targets $21.14 (+4.50%). The near-term read is upside; watch $20.85 / $19.83 because daily realized volatility is about 3.20%. | ||||
| Week | $21.99 ▲ +8.70% | Last Week | $21.49 ▼ -5.86% | The 7-day Syndax Pharmaceuticals Inc. Common Stock model moves from $21.49 to $21.99 (+8.70%). It gives upside momentum context for this stock, so breaks around $20.85 / $19.83 matter more than a single tick. |
The 7-day Syndax Pharmaceuticals Inc. Common Stock model moves from $21.49 to $21.99 (+8.70%). It gives upside momentum context for this stock, so breaks around $20.85 / $19.83 matter more than a single tick. | ||||
| Month | $21.75 ▲ +7.51% | Last Month | $24.23 ▼ -16.51% | The 1-month Syndax Pharmaceuticals Inc. Common Stock target is $21.75 (+7.51%), compared with the live reference near $20.23. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Syndax Pharmaceuticals Inc. Common Stock target is $21.75 (+7.51%), compared with the live reference near $20.23. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $20.63 ▲ +1.98% | Last Year | $9.05 ▲ +123.54% | The 1-year Syndax Pharmaceuticals Inc. Common Stock scenario points to $20.63 (+1.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Syndax Pharmaceuticals Inc. Common Stock scenario points to $20.63 (+1.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $17.86 ▼ -11.72% | 5 Years Ago | $18.45 ▲ +9.65% | The 5-year Syndax Pharmaceuticals Inc. Common Stock view is $17.86 (-11.72%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Syndax Pharmaceuticals Inc. Common Stock view is $17.86 (-11.72%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 68.1 | Bullish |
| MACD | 0.10 | Bullish |
| SMA 50 | $21.17 | Mid |
| SMA 200 | $19.86 | Above |
| EMA 20 | $20.47 | Mid |
| Opening Price | $20.43 | Start Date | 2020-01-02 |
| Day Range | $20.16 – $20.93 | Market Cap | $2.06B |
| Monthly Range | $19.11 – $24.76 | 24h Volume | n/a |
| 90D Range | $19.11 – $25.15 | Circulating | n/a |
| 52W Range | $8.73 – $25.15 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.